microRNAs and lung cancer

Abstract

Xiang Min, Zhu Ling, Chen Yan, Liu Xin, Wang Xicai. microRNAs and lung cancer[J]. Journal of International Oncology, 2015, 42(2): 144-146.

［1］ Crowell RE, Goetz T, Wiggins C, et al. Regional disparities in treatment and survival of early stage nonsmall cell lung cancer［J］. Ethn Dis, 2007, 17(2): 358-364. ［2］ Lee RC, Feinbaum RL, Ambros V. The C.elegans heterochronic gene lin4 encodes small RNAs with antisense complementarity to lin14［J］. Cell, 1993, 75(5): 843-854. ［3］ Farazi TA, Spitzer JI, Morozov P, et al. miRNAs in human cancer［J］. J Pathol, 2011, 223(2): 102-115. ［4］ KsiazekWiniarek DJ, Kacperska MJ, Glabinski A. MicroRNAs as novel regulators of neuroinflammation［J］. Mediators Inflamm, 2013, 2013: 172351. ［5］ Taft RJ, Simons C, Nahkuri S, et al. Nuclearlocalized tiny RNAs are associated with transcription initiation and splice sitesin metazoans［J］. Nat Struct Mol Biol, 2010, 17(8): 1030-1034. ［6］ Deng G, Sui G. Noncoding RNA in oncogenesis: a new era of identifying keyplayers［J］. Int J Mol Sci, 2013, 14(9): 18319-18349. ［7］ Peng Y, Dai Y, Hitchcock C, et al. Insulin growth factor signaling is regulated by microRNA486, an underexpressed microRNA in lung cancer［J］. Proc Natl Acad Sci USA, 2013, 110(37): 15043-15048. ［8］ Liu ZL, Wang H, Liu J, et al. MicroRNA21 (miR21) expression promotes growth, metastasis, and chemo or radioresistance in nonsmall cell lung cancer cells by targeting PTEN［J］. Mol Cell Biochem, 2013, 372(12): 35-45. ［9］ Gao W, Yu Y, Cao H, et al. Deregulated expression of miR21, miR143 and miR181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis［J］. Biomed Pharmacother, 2010, 64 (6): 399-408. ［10］ Yu L, Todd NW, Xing L, et al. Early detection of lung adenocarcinoma in sputum by a panel of microRNA markers［J］. Int J Cancer, 2010, 127(12): 2870-2878. ［11］ Wu X, Liu T, Fang O, et al. miR194 suppresses metastasis of nonsmall cell lung cancer through regulating expression of BMP1 and p27(kip1)［J］. Oncogene, 2014, 33(12): 1506-1514. ［12］ Gibbons DL, Lin W, Creighton CJ, et al. Contextual extracellular cues promote tumor cell EMT and metastasis by regulating miR200 family expression［J］. Genes Dev, 2009, 23(18): 21402151. ［13］ Zhao B, Han H, Chen J, et al. MicroRNA let7c inhibits migration and invasion of human nonsmall cell lung cancer by targeting ITGB3 and MAP4K3［J］. Cancer Lett, 2014, 342(1): 43-51. ［14］ Arora S, Ranade AR, Tran NL, et al. MicroRNA328 is associated with (nonsmall) cell lung cancer (NSCLC) brain metastasis and mediates NSCLC migration［J］. Int J Cancer, 2011, 129(11): 2621-2631. ［15］ Liu YJ, Lin YF, Chen YF, et al. MicroRNA449a enhances radiosensitivity in CL10 lung adenocarcinoma cells［J］. PLoS One, 2013, 8(4): e62383. ［16］ Grosso S, Doyen J, Parks SK, et al. MiR210 promotes a hypoxic phenotype and increases radioresistance in human lung cancer cell lines［J］. Cell Death Dis, 2013, 4: e544. ［17］ Qiu T, Zhou L, Wang T, et al. miR503 regulates the resistance of nonsmall cell lung cancer cells to cisplatin by targeting Bcl2［J］. Int J Mol Med, 2013, 32(3): 593-598. ［18］ Zhu X, Li H, Long L, et al. miR126 enhances the sensitivity of nonsmall cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A［J］. Acta Biochim Biophys Sin (Shanghai), 2012, 44(6): 519-526. ［19］ Franchina T, Amodeo V, Bronte G, et al. Circulating miR22, miR24 and miR34a as novel predictive biomarkers to pemetrexedbased chemotherapy in advanced nonsmall cell lung cancer［J］. J Cell Physiol, 2014, 229(1): 97-99. ［20］ Chen G, Umelo IA, Lv S, et al. miR146a inhibits cell growth, cell migration and induces apoptosis in nonsmall cell lung cancer cells［J］. PLoS One, 2013, 8(3): e60317. ［21］ Markou A, Tsaroucha EG, Kaklamanis L, et al. Prognostic value of mature microRNA21 and microRNA205 overexpression in nonsmall cell lung cancer by quantitative realtime RTPCR［J］. Clin Chem, 2008, 54(10): 1696-1704.

[1]	Liu Na, Kou Jieli, Yang Feng, Liu Taotao, Li Danping, Han Junrui, Yang Lizhou.Clinical value of serum miR-106b-5p and miR-760 combined with low-dose spiral CT in the diagnosis of early lung cancer[J]. Journal of International Oncology, 2024, 51(6): 321-325.
[2]	Gong Yan, Chen Honglei.Research progress on the mechanism of microRNA regulation of cisplatin resistance in ovarian cancer[J]. Journal of International Oncology, 2024, 51(3): 186-190.
[3]	He Jiahui, Hu Qinyong.Comparative analysis of lung cancer incidence and mortality trends and risk factors in China and the United States based on GBD data[J]. Journal of International Oncology, 2024, 51(1): 29-36.
[4]	Quan Zhenhao, Xu Feipeng, Huang Zhe, Huang Xianjin, Chen Rihong, Sun Kaiyu, Hu Xu, Lin Lin.lncRNA FTX silencing inhibits gastric cancer cell proliferation through the miR-22-3p/NLRP3 inflammasome pathway[J]. Journal of International Oncology, 2023, 50(4): 202-207.
[5]	Zuo Xiaoping, Liu Xiaochuan, Wu Xiqiang, Li Zhou, Xia Tian, Liu Guofeng.Risk factors and prediction model construction of arrhythmia in elderly patients with early lung cancer after thoracoscopic pulmonary resection[J]. Journal of International Oncology, 2023, 50(12): 711-716.
[6]	Chen Yu, Xu Hua, Liu Hai, Chen Shixin.Construction of pathological classification prediction model for malignant pulmonary pure ground-glass nodule patients based on CT imaging[J]. Journal of International Oncology, 2023, 50(11): 655-660.
[7]	Yang Sha, Yang Xiaohua, Wang Suhua, Xue Xiaoyan, Xu Jun.Analysis of risk factors for deep vein thrombosis of lower extremity after thoracoscopic surgery for elderly lung cancer and establishment and validation of prediction model[J]. Journal of International Oncology, 2022, 49(9): 532-536.
[8]	Chen Huangjing, Zhu Pengfei, Zhang Qing, Chen Guifang, Yang Chunlin, He Ying.Comparative study on the clinical value of contrast-enhanced ultrasound- and CT-guided percutaneous puncture biopsy in peripheral lung masses[J]. Journal of International Oncology, 2022, 49(8): 459-463.
[9]	Cai Gangxiang, Li Jing, Xu Bin.Advances in neoadjuvant immunotherapy for lung cancer[J]. Journal of International Oncology, 2022, 49(6): 366-370.
[10]	Zhang Jingxian, Yi Dan, Li Xiaojiang.Application of antibody-drug conjugates in the treatment of non-small cell lung cancer[J]. Journal of International Oncology, 2022, 49(5): 296-301.
[11]	Zhou Renbang, Zhang Zhongchuan, Xu Zhiyuan, Zhu Xunbing.MiR-219a-5p inhibits the proliferation, invasion and migration of osteosarcoma U2OS cells by negatively regulating HMGA2[J]. Journal of International Oncology, 2022, 49(4): 193-198.
[12]	Gao Min, Feng Jing, Wang Li, Zhong Hai, Wen Yuting, Wan Bing, Zhang Xiuwei.Application of microbiota in the early diagnosis and adjunctive treatment of lung cancer[J]. Journal of International Oncology, 2022, 49(4): 247-251.
[13]	Gao Shile, Lu Donghui, Liu Meiqin, Xu Xingjun, Ma Huan, Zhang Yu.Clinical efficacy and optimal dose of apatinib combined with chemotherapy in patients with advanced non-small cell lung cancer[J]. Journal of International Oncology, 2022, 49(3): 140-145.
[14]	Xie Hongxia, Zuo Jinhui, Liao Dongying, Deng Renfen, Yao Yang, Jia Yingjie, Li Xiaojiang, Kong Fanming.Application of PD-L1 inhibitors in the treatment of non-small cell lung cancer[J]. Journal of International Oncology, 2022, 49(2): 111-115.
[15]	Huang Huayu, Song Qibin, Gong Hongyun, Song Jia.Analysis on the incidence and risk factors of pneumonia in patients with lung cancer receiving thoracic radiotherapy and immunotherapy[J]. Journal of International Oncology, 2022, 49(12): 718-723.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles15

Recommended Articles

Metrics

Comments